InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.061

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Leading Patient NGO Endorses FerriScan and AI Technology 21 Jun 2017 10:51AM $0.027 $0.061 risen by 125.93%
$29 Artificial Intelligence Solution for Emerging Markets 14 Jun 2017 12:47AM $0.018 $0.061 risen by 238.89%
$29 Quarterly Report 28 Apr 2017 3:51PM $0.022 $0.061 risen by 177.27%
$29 FerriScan not impacted by Fatty Liver 18 Apr 2017 2:33PM $0.024 $0.061 risen by 154.17%
$29 Evidence Building for HepaFat-Scan 12 Apr 2017 10:21AM $0.021 $0.061 risen by 190.48%
$29 Appendix 3Y Panton 5 Apr 2017 4:51PM $0.023 $0.061 risen by 165.22%
$29 Customer Newsletter - March 2017 30 Mar 2017 5:02PM $0.023 $0.061 risen by 165.22%
$29 Cancer Survivor Campaign Update 23 Mar 2017 2:24PM $0.022 $0.061 risen by 177.27%
$29 Updated Securities Trading Policy 1 Mar 2017 6:22PM $0.021 $0.061 risen by 190.48%
$29 Half year report 28 Feb 2017 5:46PM $0.021 $0.061 risen by 190.48%
$29 Change in substantial holding 9 Feb 2017 4:02PM $0.024 $0.061 risen by 154.17%
$29 Appendix 4C - quarterly 31 Jan 2017 12:25AM $0.025 $0.061 risen by 144%
$29 Maylasian NAFLD - Diabetes Study 12 Jan 2017 1:36PM $0.027 $0.061 risen by 125.93%
$29 Customer Newsletter December 2016 23 Dec 2016 3:11PM $0.026 $0.061 risen by 134.62%
$29 FerriScan use showcased at ASH conference 15 Dec 2016 12:02AM $0.026 $0.061 risen by 134.62%
$29 Equity Research Report Released 1 Dec 2016 3:24PM $0.023 $0.061 risen by 165.22%
$29 Initial Director's Interest Notice 28 Nov 2016 1:49PM $0.025 $0.061 risen by 144%
$29 Results of Meeting 24 Nov 2016 3:05PM $0.025 $0.061 risen by 144%
$29 Annual General Meeting Presentation 24 Nov 2016 1:03PM $0.025 $0.061 risen by 144%
$29 Director Appointment 16 Nov 2016 12:13AM $0.023 $0.061 risen by 165.22%
$29 Results Recommending Use of FerriScan in Sickle Cell Disease 10 Nov 2016 11:48AM $0.022 $0.061 risen by 177.27%
$29 Change in substantial holding 9 Nov 2016 2:55PM $0.020 $0.061 risen by 205%
$29 Appendix 4C - quarterly 28 Oct 2016 3:52PM $0.027 $0.061 risen by 125.93%
$29 Notice of Annual General Meeting/Proxy Form 24 Oct 2016 5:32PM $0.028 $0.061 risen by 117.86%
$29 Annual Report to shareholders 24 Oct 2016 2:14PM $0.028 $0.061 risen by 117.86%

326 - 350 of 532 results

Page 14 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.